The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Infectious Disease Rapid Diagnostic Testing Market Research Report 2025

Global Infectious Disease Rapid Diagnostic Testing Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1927672

No of Pages : 96

Synopsis

The global Infectious Disease Rapid Diagnostic Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Infectious Disease Rapid Diagnostic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Disease Rapid Diagnostic Testing.

Report Scope

The Infectious Disease Rapid Diagnostic Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Infectious Disease Rapid Diagnostic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Infectious Disease Rapid Diagnostic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company (Partial List)

  • Abbott Laboratories
  • Roche Ltd
  • Danaher Corporation
  • Luminex Corporation
  • BGI Group
  • bioMerieux S.A.
  • DiaSorin S.p.A
  • Hologic, Inc.
  • Mesa Biotech
  • Quidel Corporation
  • Thermo Fisher Scientific Inc.
  • GenMark Diagnostics
  • CTK Biotech
  • Becton Dickinson
  • Cellex Inc.

Segment by Type

  • Assays
  • Platforms

Segment by Application

  • Respiratory Infection
  • Gastro-Intestinal Infection
  • Center Nervous System Infection
  • Hospital Acquired Infection
  • Sexually Transmitted Infections
  • Others

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Infectious Disease Rapid Diagnostic Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infectious Disease Rapid Diagnostic Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Assays
1.2.3 Platforms
1.3 Market by Application
1.3.1 Global Infectious Disease Rapid Diagnostic Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Respiratory Infection
1.3.3 Gastro-Intestinal Infection
1.3.4 Center Nervous System Infection
1.3.5 Hospital Acquired Infection
1.3.6 Sexually Transmitted Infections
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Infectious Disease Rapid Diagnostic Testing Market Perspective (2019-2030)
2.2 Infectious Disease Rapid Diagnostic Testing Growth Trends by Region
2.2.1 Global Infectious Disease Rapid Diagnostic Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Infectious Disease Rapid Diagnostic Testing Historic Market Size by Region (2019-2024)
2.2.3 Infectious Disease Rapid Diagnostic Testing Forecasted Market Size by Region (2025-2030)
2.3 Infectious Disease Rapid Diagnostic Testing Market Dynamics
2.3.1 Infectious Disease Rapid Diagnostic Testing Industry Trends
2.3.2 Infectious Disease Rapid Diagnostic Testing Market Drivers
2.3.3 Infectious Disease Rapid Diagnostic Testing Market Challenges
2.3.4 Infectious Disease Rapid Diagnostic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infectious Disease Rapid Diagnostic Testing Players by Revenue
3.1.1 Global Top Infectious Disease Rapid Diagnostic Testing Players by Revenue (2019-2024)
3.1.2 Global Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Players (2019-2024)
3.2 Global Infectious Disease Rapid Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Infectious Disease Rapid Diagnostic Testing Revenue
3.4 Global Infectious Disease Rapid Diagnostic Testing Market Concentration Ratio
3.4.1 Global Infectious Disease Rapid Diagnostic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease Rapid Diagnostic Testing Revenue in 2023
3.5 Infectious Disease Rapid Diagnostic Testing Key Players Head office and Area Served
3.6 Key Players Infectious Disease Rapid Diagnostic Testing Product Solution and Service
3.7 Date of Enter into Infectious Disease Rapid Diagnostic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Infectious Disease Rapid Diagnostic Testing Breakdown Data by Type
4.1 Global Infectious Disease Rapid Diagnostic Testing Historic Market Size by Type (2019-2024)
4.2 Global Infectious Disease Rapid Diagnostic Testing Forecasted Market Size by Type (2025-2030)
5 Infectious Disease Rapid Diagnostic Testing Breakdown Data by Application
5.1 Global Infectious Disease Rapid Diagnostic Testing Historic Market Size by Application (2019-2024)
5.2 Global Infectious Disease Rapid Diagnostic Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Infectious Disease Rapid Diagnostic Testing Market Size (2019-2030)
6.2 North America Infectious Disease Rapid Diagnostic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Infectious Disease Rapid Diagnostic Testing Market Size by Country (2019-2024)
6.4 North America Infectious Disease Rapid Diagnostic Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Infectious Disease Rapid Diagnostic Testing Market Size (2019-2030)
7.2 Europe Infectious Disease Rapid Diagnostic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Infectious Disease Rapid Diagnostic Testing Market Size by Country (2019-2024)
7.4 Europe Infectious Disease Rapid Diagnostic Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Infectious Disease Rapid Diagnostic Testing Market Size (2019-2030)
8.2 Asia-Pacific Infectious Disease Rapid Diagnostic Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Infectious Disease Rapid Diagnostic Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Infectious Disease Rapid Diagnostic Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Infectious Disease Rapid Diagnostic Testing Market Size (2019-2030)
9.2 Latin America Infectious Disease Rapid Diagnostic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Infectious Disease Rapid Diagnostic Testing Market Size by Country (2019-2024)
9.4 Latin America Infectious Disease Rapid Diagnostic Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infectious Disease Rapid Diagnostic Testing Market Size (2019-2030)
10.2 Middle East & Africa Infectious Disease Rapid Diagnostic Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Infectious Disease Rapid Diagnostic Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Infectious Disease Rapid Diagnostic Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Infectious Disease Rapid Diagnostic Testing Introduction
11.1.4 Abbott Laboratories Revenue in Infectious Disease Rapid Diagnostic Testing Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 Roche Ltd
11.2.1 Roche Ltd Company Detail
11.2.2 Roche Ltd Business Overview
11.2.3 Roche Ltd Infectious Disease Rapid Diagnostic Testing Introduction
11.2.4 Roche Ltd Revenue in Infectious Disease Rapid Diagnostic Testing Business (2019-2024)
11.2.5 Roche Ltd Recent Development
11.3 Danaher Corporation
11.3.1 Danaher Corporation Company Detail
11.3.2 Danaher Corporation Business Overview
11.3.3 Danaher Corporation Infectious Disease Rapid Diagnostic Testing Introduction
11.3.4 Danaher Corporation Revenue in Infectious Disease Rapid Diagnostic Testing Business (2019-2024)
11.3.5 Danaher Corporation Recent Development
11.4 Luminex Corporation
11.4.1 Luminex Corporation Company Detail
11.4.2 Luminex Corporation Business Overview
11.4.3 Luminex Corporation Infectious Disease Rapid Diagnostic Testing Introduction
11.4.4 Luminex Corporation Revenue in Infectious Disease Rapid Diagnostic Testing Business (2019-2024)
11.4.5 Luminex Corporation Recent Development
11.5 BGI Group
11.5.1 BGI Group Company Detail
11.5.2 BGI Group Business Overview
11.5.3 BGI Group Infectious Disease Rapid Diagnostic Testing Introduction
11.5.4 BGI Group Revenue in Infectious Disease Rapid Diagnostic Testing Business (2019-2024)
11.5.5 BGI Group Recent Development
11.6 bioMerieux S.A.
11.6.1 bioMerieux S.A. Company Detail
11.6.2 bioMerieux S.A. Business Overview
11.6.3 bioMerieux S.A. Infectious Disease Rapid Diagnostic Testing Introduction
11.6.4 bioMerieux S.A. Revenue in Infectious Disease Rapid Diagnostic Testing Business (2019-2024)
11.6.5 bioMerieux S.A. Recent Development
11.7 DiaSorin S.p.A
11.7.1 DiaSorin S.p.A Company Detail
11.7.2 DiaSorin S.p.A Business Overview
11.7.3 DiaSorin S.p.A Infectious Disease Rapid Diagnostic Testing Introduction
11.7.4 DiaSorin S.p.A Revenue in Infectious Disease Rapid Diagnostic Testing Business (2019-2024)
11.7.5 DiaSorin S.p.A Recent Development
11.8 Hologic, Inc.
11.8.1 Hologic, Inc. Company Detail
11.8.2 Hologic, Inc. Business Overview
11.8.3 Hologic, Inc. Infectious Disease Rapid Diagnostic Testing Introduction
11.8.4 Hologic, Inc. Revenue in Infectious Disease Rapid Diagnostic Testing Business (2019-2024)
11.8.5 Hologic, Inc. Recent Development
11.9 Mesa Biotech
11.9.1 Mesa Biotech Company Detail
11.9.2 Mesa Biotech Business Overview
11.9.3 Mesa Biotech Infectious Disease Rapid Diagnostic Testing Introduction
11.9.4 Mesa Biotech Revenue in Infectious Disease Rapid Diagnostic Testing Business (2019-2024)
11.9.5 Mesa Biotech Recent Development
11.10 Quidel Corporation
11.10.1 Quidel Corporation Company Detail
11.10.2 Quidel Corporation Business Overview
11.10.3 Quidel Corporation Infectious Disease Rapid Diagnostic Testing Introduction
11.10.4 Quidel Corporation Revenue in Infectious Disease Rapid Diagnostic Testing Business (2019-2024)
11.10.5 Quidel Corporation Recent Development
11.11 Thermo Fisher Scientific Inc.
11.11.1 Thermo Fisher Scientific Inc. Company Detail
11.11.2 Thermo Fisher Scientific Inc. Business Overview
11.11.3 Thermo Fisher Scientific Inc. Infectious Disease Rapid Diagnostic Testing Introduction
11.11.4 Thermo Fisher Scientific Inc. Revenue in Infectious Disease Rapid Diagnostic Testing Business (2019-2024)
11.11.5 Thermo Fisher Scientific Inc. Recent Development
11.12 GenMark Diagnostics
11.12.1 GenMark Diagnostics Company Detail
11.12.2 GenMark Diagnostics Business Overview
11.12.3 GenMark Diagnostics Infectious Disease Rapid Diagnostic Testing Introduction
11.12.4 GenMark Diagnostics Revenue in Infectious Disease Rapid Diagnostic Testing Business (2019-2024)
11.12.5 GenMark Diagnostics Recent Development
11.13 CTK Biotech
11.13.1 CTK Biotech Company Detail
11.13.2 CTK Biotech Business Overview
11.13.3 CTK Biotech Infectious Disease Rapid Diagnostic Testing Introduction
11.13.4 CTK Biotech Revenue in Infectious Disease Rapid Diagnostic Testing Business (2019-2024)
11.13.5 CTK Biotech Recent Development
11.14 Becton Dickinson
11.14.1 Becton Dickinson Company Detail
11.14.2 Becton Dickinson Business Overview
11.14.3 Becton Dickinson Infectious Disease Rapid Diagnostic Testing Introduction
11.14.4 Becton Dickinson Revenue in Infectious Disease Rapid Diagnostic Testing Business (2019-2024)
11.14.5 Becton Dickinson Recent Development
11.15 Cellex Inc.
11.15.1 Cellex Inc. Company Detail
11.15.2 Cellex Inc. Business Overview
11.15.3 Cellex Inc. Infectious Disease Rapid Diagnostic Testing Introduction
11.15.4 Cellex Inc. Revenue in Infectious Disease Rapid Diagnostic Testing Business (2019-2024)
11.15.5 Cellex Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Infectious Disease Rapid Diagnostic Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Assays
Table 3. Key Players of Platforms
Table 4. Global Infectious Disease Rapid Diagnostic Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Infectious Disease Rapid Diagnostic Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Infectious Disease Rapid Diagnostic Testing Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Infectious Disease Rapid Diagnostic Testing Market Share by Region (2019-2024)
Table 8. Global Infectious Disease Rapid Diagnostic Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Infectious Disease Rapid Diagnostic Testing Market Share by Region (2025-2030)
Table 10. Infectious Disease Rapid Diagnostic Testing Market Trends
Table 11. Infectious Disease Rapid Diagnostic Testing Market Drivers
Table 12. Infectious Disease Rapid Diagnostic Testing Market Challenges
Table 13. Infectious Disease Rapid Diagnostic Testing Market Restraints
Table 14. Global Infectious Disease Rapid Diagnostic Testing Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Infectious Disease Rapid Diagnostic Testing Market Share by Players (2019-2024)
Table 16. Global Top Infectious Disease Rapid Diagnostic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Rapid Diagnostic Testing as of 2023)
Table 17. Ranking of Global Top Infectious Disease Rapid Diagnostic Testing Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Infectious Disease Rapid Diagnostic Testing Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Infectious Disease Rapid Diagnostic Testing Product Solution and Service
Table 21. Date of Enter into Infectious Disease Rapid Diagnostic Testing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Infectious Disease Rapid Diagnostic Testing Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Type (2019-2024)
Table 25. Global Infectious Disease Rapid Diagnostic Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Type (2025-2030)
Table 27. Global Infectious Disease Rapid Diagnostic Testing Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Application (2019-2024)
Table 29. Global Infectious Disease Rapid Diagnostic Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Infectious Disease Rapid Diagnostic Testing Revenue Market Share by Application (2025-2030)
Table 31. North America Infectious Disease Rapid Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Infectious Disease Rapid Diagnostic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Infectious Disease Rapid Diagnostic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Infectious Disease Rapid Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Infectious Disease Rapid Diagnostic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Infectious Disease Rapid Diagnostic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Infectious Disease Rapid Diagnostic Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Infectious Disease Rapid Diagnostic Testing Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Infectious Disease Rapid Diagnostic Testing Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Infectious Disease Rapid Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Infectious Disease Rapid Diagnostic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Infectious Disease Rapid Diagnostic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Infectious Disease Rapid Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Infectious Disease Rapid Diagnostic Testing Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Infectious Disease Rapid Diagnostic Testing Market Size by Country (2025-2030) & (US$ Million)
Table 46. Abbott Laboratories Company Detail
Table 47. Abbott Laboratories Business Overview
Table 48. Abbott Laboratories Infectious Disease Rapid Diagnostic Testing Product
Table 49. Abbott Laboratories Revenue in Infectious Disease Rapid Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 50. Abbott Laboratories Recent Development
Table 51. Roche Ltd Company Detail
Table 52. Roche Ltd Business Overview
Table 53. Roche Ltd Infectious Disease Rapid Diagnostic Testing Product
Table 54. Roche Ltd Revenue in Infectious Disease Rapid Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 55. Roche Ltd Recent Development
Table 56. Danaher Corporation Company Detail
Table 57. Danaher Corporation Business Overview
Table 58. Danaher Corporation Infectious Disease Rapid Diagnostic Testing Product
Table 59. Danaher Corporation Revenue in Infectious Disease Rapid Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 60. Danaher Corporation Recent Development
Table 61. Luminex Corporation Company Detail
Table 62. Luminex Corporation Business Overview
Table 63. Luminex Corporation Infectious Disease Rapid Diagnostic Testing Product
Table 64. Luminex Corporation Revenue in Infectious Disease Rapid Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 65. Luminex Corporation Recent Development
Table 66. BGI Group Company Detail
Table 67. BGI Group Business Overview
Table 68. BGI Group Infectious Disease Rapid Diagnostic Testing Product
Table 69. BGI Group Revenue in Infectious Disease Rapid Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 70. BGI Group Recent Development
Table 71. bioMerieux S.A. Company Detail
Table 72. bioMerieux S.A. Business Overview
Table 73. bioMerieux S.A. Infectious Disease Rapid Diagnostic Testing Product
Table 74. bioMerieux S.A. Revenue in Infectious Disease Rapid Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 75. bioMerieux S.A. Recent Development
Table 76. DiaSorin S.p.A Company Detail
Table 77. DiaSorin S.p.A Business Overview
Table 78. DiaSorin S.p.A Infectious Disease Rapid Diagnostic Testing Product
Table 79. DiaSorin S.p.A Revenue in Infectious Disease Rapid Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 80. DiaSorin S.p.A Recent Development
Table 81. Hologic, Inc. Company Detail
Table 82. Hologic, Inc. Business Overview
Table 83. Hologic, Inc. Infectious Disease Rapid Diagnostic Testing Product
Table 84. Hologic, Inc. Revenue in Infectious Disease Rapid Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 85. Hologic, Inc. Recent Development
Table 86. Mesa Biotech Company Detail
Table 87. Mesa Biotech Business Overview
Table 88. Mesa Biotech Infectious Disease Rapid Diagnostic Testing Product
Table 89. Mesa Biotech Revenue in Infectious Disease Rapid Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 90. Mesa Biotech Recent Development
Table 91. Quidel Corporation Company Detail
Table 92. Quidel Corporation Business Overview
Table 93. Quidel Corporation Infectious Disease Rapid Diagnostic Testing Product
Table 94. Quidel Corporation Revenue in Infectious Disease Rapid Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 95. Quidel Corporation Recent Development
Table 96. Thermo Fisher Scientific Inc. Company Detail
Table 97. Thermo Fisher Scientific Inc. Business Overview
Table 98. Thermo Fisher Scientific Inc. Infectious Disease Rapid Diagnostic Testing Product
Table 99. Thermo Fisher Scientific Inc. Revenue in Infectious Disease Rapid Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 100. Thermo Fisher Scientific Inc. Recent Development
Table 101. GenMark Diagnostics Company Detail
Table 102. GenMark Diagnostics Business Overview
Table 103. GenMark Diagnostics Infectious Disease Rapid Diagnostic Testing Product
Table 104. GenMark Diagnostics Revenue in Infectious Disease Rapid Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 105. GenMark Diagnostics Recent Development
Table 106. CTK Biotech Company Detail
Table 107. CTK Biotech Business Overview
Table 108. CTK Biotech Infectious Disease Rapid Diagnostic Testing Product
Table 109. CTK Biotech Revenue in Infectious Disease Rapid Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 110. CTK Biotech Recent Development
Table 111. Becton Dickinson Company Detail
Table 112. Becton Dickinson Business Overview
Table 113. Becton Dickinson Infectious Disease Rapid Diagnostic Testing Product
Table 114. Becton Dickinson Revenue in Infectious Disease Rapid Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 115. Becton Dickinson Recent Development
Table 116. Cellex Inc. Company Detail
Table 117. Cellex Inc. Business Overview
Table 118. Cellex Inc. Infectious Disease Rapid Diagnostic Testing Product
Table 119. Cellex Inc. Revenue in Infectious Disease Rapid Diagnostic Testing Business (2019-2024) & (US$ Million)
Table 120. Cellex Inc. Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Infectious Disease Rapid Diagnostic Testing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Infectious Disease Rapid Diagnostic Testing Market Share by Type: 2023 VS 2030
Figure 3. Assays Features
Figure 4. Platforms Features
Figure 5. Global Infectious Disease Rapid Diagnostic Testing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Infectious Disease Rapid Diagnostic Testing Market Share by Application: 2023 VS 2030
Figure 7. Respiratory Infection Case Studies
Figure 8. Gastro-Intestinal Infection Case Studies
Figure 9. Center Nervous System Infection Case Studies
Figure 10. Hospital Acquired Infection Case Studies
Figure 11. Sexually Transmitted Infections Case Studies
Figure 12. Others Case Studies
Figure 13. Infectious Disease Rapid Diagnostic Testing Report Years Considered
Figure 14. Global Infectious Disease Rapid Diagnostic Testing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Infectious Disease Rapid Diagnostic Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Infectious Disease Rapid Diagnostic Testing Market Share by Region: 2023 VS 2030
Figure 17. Global Infectious Disease Rapid Diagnostic Testing Market Share by Players in 2023
Figure 18. Global Top Infectious Disease Rapid Diagnostic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Disease Rapid Diagnostic Testing as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Infectious Disease Rapid Diagnostic Testing Revenue in 2023
Figure 20. North America Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Infectious Disease Rapid Diagnostic Testing Market Share by Country (2019-2030)
Figure 22. United States Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Infectious Disease Rapid Diagnostic Testing Market Share by Country (2019-2030)
Figure 26. Germany Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Infectious Disease Rapid Diagnostic Testing Market Share by Region (2019-2030)
Figure 34. China Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Infectious Disease Rapid Diagnostic Testing Market Share by Country (2019-2030)
Figure 42. Mexico Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Infectious Disease Rapid Diagnostic Testing Market Share by Country (2019-2030)
Figure 46. Turkey Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Infectious Disease Rapid Diagnostic Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Abbott Laboratories Revenue Growth Rate in Infectious Disease Rapid Diagnostic Testing Business (2019-2024)
Figure 49. Roche Ltd Revenue Growth Rate in Infectious Disease Rapid Diagnostic Testing Business (2019-2024)
Figure 50. Danaher Corporation Revenue Growth Rate in Infectious Disease Rapid Diagnostic Testing Business (2019-2024)
Figure 51. Luminex Corporation Revenue Growth Rate in Infectious Disease Rapid Diagnostic Testing Business (2019-2024)
Figure 52. BGI Group Revenue Growth Rate in Infectious Disease Rapid Diagnostic Testing Business (2019-2024)
Figure 53. bioMerieux S.A. Revenue Growth Rate in Infectious Disease Rapid Diagnostic Testing Business (2019-2024)
Figure 54. DiaSorin S.p.A Revenue Growth Rate in Infectious Disease Rapid Diagnostic Testing Business (2019-2024)
Figure 55. Hologic, Inc. Revenue Growth Rate in Infectious Disease Rapid Diagnostic Testing Business (2019-2024)
Figure 56. Mesa Biotech Revenue Growth Rate in Infectious Disease Rapid Diagnostic Testing Business (2019-2024)
Figure 57. Quidel Corporation Revenue Growth Rate in Infectious Disease Rapid Diagnostic Testing Business (2019-2024)
Figure 58. Thermo Fisher Scientific Inc. Revenue Growth Rate in Infectious Disease Rapid Diagnostic Testing Business (2019-2024)
Figure 59. GenMark Diagnostics Revenue Growth Rate in Infectious Disease Rapid Diagnostic Testing Business (2019-2024)
Figure 60. CTK Biotech Revenue Growth Rate in Infectious Disease Rapid Diagnostic Testing Business (2019-2024)
Figure 61. Becton Dickinson Revenue Growth Rate in Infectious Disease Rapid Diagnostic Testing Business (2019-2024)
Figure 62. Cellex Inc. Revenue Growth Rate in Infectious Disease Rapid Diagnostic Testing Business (2019-2024)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’